Financials: The Delicate Balance of Rates and Yield Curve

The financial cohort is in a difficult space as the broader economic backdrop continues to dictate whether these stocks can appreciate higher. A delicate balance between interest rates, Federal Reserve commentary, yield curve inversion, trade war, and concerns over a potential recession in late 2019 or early 2020 must be attained. A disruption in this complex web can lead to the financials breaking down as witnessed in Q4 2018 and in May of 2019. In Q4 2018 rates were increased by the Federal Reserve and sent the financials in a downward tailspin. In May 2019, a trifecta of a yield curve inversion, trade war concerns, and increased chatter about a potential recession on the horizon again sent the cohort lower. The broader market appreciated markedly in June, and the bank stocks participated in the rally. Coupled with renewed record share buybacks and increased dividend payouts stemming from successful stress tests, banks elevated higher on the news. Now, the market is anticipating that the Federal Reserve will cut rates at its next meeting, which may serve as another catalyst to propel some bank stocks to new 52-week highs.

The Q4 2018 Federal Reserve and Jerome Powell

The market-wide sell-off in the fourth quarter of 2018 was largely induced by the Federal Reserve and its alleged commitment to sequential interest rate increases into 2019. This was largely viewed as reckless and misguided while turning a blind eye to broader economic data-driven decision making about further interest rate hikes. The stock indices responded to the sequential interest rate hike stance with overwhelming negative sentiment, logging double-digit declines across the broader markets. Many market observers were questioning the Federal Reserve’s aggressive stance as companies issued weakness in ancillary economic metrics (slowing global growth, strong U.S. dollar, trade war, government shutdown, weak housing numbers, retail weakness, auto sluggishness, and oil decline) as an indication that cracks in the economic cycle were materializing. The strong labor market and record low unemployment served as a basis to rationalize increasing rates to tame inflation; however, these aforementioned economic headwinds appeared to cause the Federal Reserve to pivot in its aggressive stance. As Chairman Jerome Powell began to issue a softer stance on future interest rate hikes, January saw very healthy stock market gains after being decimated for months prior. On January 30th, Jerome Powell issued language that the markets were craving to levitate higher as he left interest rates unchanged and exercised caution and patience as a path forward. Using data-driven decision making as a path forward was cheered by market participants as the broader indices popped for healthy gains on top of the already robust gains throughout January. Continue reading "Financials: The Delicate Balance of Rates and Yield Curve"

Will CVS Health and Walgreens Survive?

Is it the single payer narrative being pushed by Democratic Presidential frontrunners? Is it the Amazon threat via its acquisitions of PillPack and Whole Foods that may displace traditional pharmacies? Is it the drug pricing pressures that are eroding margins and limiting margin expansion over time? Is it the secular decline in the physical footprint storefront retail space that’s hindering foot traffic and off-the-shelf purchases? Regardless of whether or not it’s singularly attributable to one of these factors or the culmination of all the aforementioned factors, CVS Health (CVS) and Walgreens Boots Alliance (WBA) are being pressured in many different directions. CVS and Walgreens have plummeted by 53% ($113 to $53) and 46% ($97 to $52), respectively from their multi-year highs. Over $110 billion in combined market capitalization has been erased from these two companies. With threats coming from all angles, will these two pharmaceutical supply chain heavyweights be able to not only survive but compete and revive their dominance in the marketplace?

Backdrop and Market Dynamics

The pharmaceutical supply chain cohort, specifically CVS and Walgreens, are simply unable to obtain firm footing in the backdrop of consolidation within the sector, negative legislative undertones, drug pricing pressures, rising insurance costs and a market that has lost patience with these stocks. All of these factors culminate into sub-par growth with a level of uncertainty as this sector continues to face headwinds from multiple directions. Many of the stocks that comprised this cohort presented compelling valuations in a very frothy market. This allure has been a value trap as these stocks continue to be a falling knife. It’s no secret that these companies have been faced with several headwinds that have negatively impacted the growth and the changing marketplace conditions have plagued these stocks. Continue reading "Will CVS Health and Walgreens Survive?"

All-Time High - Growth Initiatives Propelling Disney

Disney (DIS) has broken out to all-time as their growth initiatives are beginning to bear fruit with Wall Street embracing its growth strategy and rewarding shares with a higher price-to-earnings multiple. Disney is firing on all cylinders; posting one record-setting blockbuster after another, wrestling away full ownership of Hulu, launching a branded streaming service, record revenue numbers via pricing power at its Parks and Resorts and remediation of its ESPN franchise with ESPN Plus. Disney’s Avengers: Endgame is taking the torch beyond the $2 billion box office milestone, a feat that’s only been accomplished four times, one of them being Avengers: Infinity War last. Endgame has its sights set on surpassing Avatar as the highest grossing movie of all-time. All the initiatives that Disney has taken over the previous few years to restore growth appear to be coming to fruition, namely it's Fox acquisition, and it's streaming initiatives. Disney continues to invest heavily into its streaming services (Hulu, ESPN Plus, and its Disney branded streaming service) to propel its growth and presence within this space. ESPN Plus launched less than a year ago and already has over 2 million subscribers. The company is evolving to meet the new age of media consumption demands of the modern consumer via streaming and on-demand content. I’ve been behind Disney for a long time, especially through this transition back to growth when the stock traded below $100 and I still feel that the company offers a compelling long-term investment opportunity given its growth catalysts that will continue to bear fruit over the coming years. However, given that the shares are at all-time highs in the backdrop of the longest bull market in history, caution is prudent.

New Star Wars Land

Disney has finally launched its much anticipated Star Wars: Galaxy's Edge at Disneyland in Anaheim, CA, with a dedication ceremony. The festivities included CEO Bob Iger and Star Wars legends including creator George Lucas and stars Mark Hamill, Billy Dee Williams, and Harrison Ford.

“Isn’t this fantastic?” Iger said as he came out in front of the full-scale Millennium Falcon. “I have been in this job for 14 years. There are some good days, but this is right up there with the best of them.” Continue reading "All-Time High - Growth Initiatives Propelling Disney"

AMC/Avengers: Endgame Propelling Box Office Numbers

Avengers: Endgame has shattered virtually every box office record with the elusive worldwide top grosser, Avatar in its sights. Avengers: Endgame and its unheard of box office numbers came on the heels of Captain Marvel which initially pumped life back into the domestic box office, delivering an epic $153 million opening weekend debut, while hauling in $455 million worldwide. AMC Entertainment Holdings Inc. (AMC) stands to benefit significantly across its business segments due to the popularity of the Marvel franchise and a robust slate of movies for the remainder of 2019. AMC will likely have a nice catalyst as the slate of 2019 movies roll out, and the box office numbers strengthen over the next nine months. To smooth out these box office revenue fluctuations, AMC has a rapidly growing loyalty program with over 800,000 members to evolve a large segment of its business mix towards a subscription-based model. This will allow durable and predictable revenue streams in the backdrop of changing box office dynamics. AMC offers a great dividend yield of over 5% and accelerating revenue and EPS growth. The company is reengaging the consumer via digital, mobile, and loyalty program options, reformatting theaters to enhance the user experience and international expansion augmented by a healthy share buyback program. The stock looks very attractive, considering its depressed valuation, solid Q1 earnings, and company initiatives to drive the consumer experience. The long term growth narrative remains intact while revenue continues to grow at a healthy clip with a healthy 9-month movie slate ahead for the remainder of 2019.

Impressive Back-to-Back Quarterly Numbers

AMC has been firing on all segments of its business on improving fundamentals across the entire enterprise over the previous two quarters. For Q4 2018, AMC beat on both the top and bottom line with EPS beating by $0.22 and revenue beating by $10 million. Q4 attendance in the U.S. set a record for the fourth quarter and coupled with the quarterly numbers; the stock popped 10%. Q1 2019, historically its weakest quarter was going against a very tough comparable year-ago quarter that included Black Panther. Considering this tough year-over-year comparable, attendance per screen declined 10.1%, and total attendance was down 12.2% year-over-year. However, food and beverage per attendee came in at a record for Q1. Taken together, revenue was down 13% at $1.2 billion however this beat consensus estimates by $10 million.

Looking ahead, AMC expects better traffic. "We have high expectations for 2019, due to an extraordinary slate of movies coming, the timing of releases within the film slate suggests that it will be a back-end loaded year," says CEO Adam Aron.

“Even with the anticipated slow start to the year, we have been and continue to be quite bullish about the full year prospects for AMC. Also, the first quarter of 2019 faced a tough year-over-year comparison, as Black Panther last year made the first quarter of 2018, the second highest grossing first quarter of all time. As we thought it was likely for our U.S. theatres, in our largest market by far, the U.S. industry box office declined a healthy 16.2% this quarter. Even so, we are comforted that AMC continued to outperform the U.S. industry box office, notably with domestic attendance per screen declining only 10.1% in the first quarter of 2019. Additionally, our U.S. food and beverage capture of $5.23 per patron set a new first-quarter record for our company. This all is largely attributable to the power of the AMC platform: stemming from experiential initiatives and enhancements at our theatres; a frictionless use of technology to communicate, engage and sell to our guests; combined with the soaring popularity of our AMC Stubs loyalty program and our AMC Stubs A-List subscription program.”

“Accordingly, we continue to be excited about the remainder of 2019, which we believe might be the highest grossing 9-month period in cinema history. We are optimistic that the full year 2019 box office will be at least as strong as 2018, and potentially could be the first year ever that the domestic box office breaks $12 billion.”
Adam Aron, CEO, and President of AMC

It’s noteworthy to point out that the full year of 2018, the U.S. box office was up 6.9% to $11.9 billion, marking the highest grossing year ever recorded with February, April, June, and October setting all-time box office monthly records. Given the slate of movies over the next 9-month period, AMC thinks it’s entirely possible to eclipse the full year 2018 numbers.

2019 Box Office Comes Alive

Disney (DIS) has finally released its first highly anticipated film of 2019 with Captain Marvel (the first female lead for a Marvel film). The film has performed exceptionally well, delivering an opening weekend box office gross of $457 million worldwide and $153 million domestically. The first two months of the year for the domestic box office has been a struggle relative to 2018. Captain Marvel brought in the third highest March opening of all-time and placed the film on par with past blockbusters such as The Dark Knight, The Hunger Games and Rouge One. On the heels of Captain Marvel was, of course, the elephant in the room, Avengers: Endgame which shattered nearly every record at the box office and aiming to take out Avatar as the highest grossing movie of all-time (Figure 1). Avengers: Endgame has generated $780 million at the domestic box office and $2.62 billion worldwide. On the domestic front, the film stands as the second highest grossing film behind Star Wars: The Force Awakens with $936.6 million. On the international front, the film currently stands in a close second behind Avatar with $2.788 billion. Disney alone has Aladdin, Toy Story 4, Lion King, Frozen 2 and Star Wars Episode 9 in its slate of films that will bode well for the box office on the domestic front as these films stand to rack in billions in box office receipts.

Box Office
Figure 1 – Avengers: Endgame shattered nearly every box office record domestically and internationally

Loyalty Game-Changer

AMC’s loyalty program now has over 800,000 subscribers, which is expected to generate more than $150 million of annual recurring revenue. This will provide further penetration on the revenue front in excess of $300 million when factoring in food and beverage purchases and full fare tickets purchased by bring-along guests such as family and friends. The loyalty program provides an opportunity to shift a segment of its business mix to a subscription-based model, providing durable and predictable revenue streams, mitigating box office fluctuations, and driving long-term customer loyalty. Under this ticket subscription program, members can attend up to three movies per week in every available showtime and format. These membership numbers far exceed the company’s goal of 500,000 by mid-June 2019.

Due in large part to the loyalty program, B. Riley FBR upgraded shares of AMC to a buy. Summer is coming and "The impressive advance ticket sales for Avengers: Endgame signals the start of the spring/summer period and we are increasingly optimistic around the potential contribution of Stubs A-List," analyst Eric Wold says. The company will keep maximizing the attractiveness of the subscription plan "as well as the efficiency/profitability of the plan to the company." The firm raised its price target to $20 from $18.

Conclusion

Avengers: Endgame provided a much-needed jolt to start off the remaining 9-month period to close out 2019. AMC is optimistic that the strong slate of movies coming out over the next nine months may propel the year-end box office numbers to eclipse the record numbers seen in 2018. AMC is sitting on a host of positive tailwinds despite the slow start to the 2019 box office numbers domestically. A large slate of movies is just now beginning to be released with Captain Marvel and Avengers: Endgame. AMC is reengaging the consumer via digital, mobile, and loyalty program options, reformatting theaters to enhance the user experience and international expansion. The loyalty program now has over 800,000 members and provides an opportunity to shift a segment of its business mix to a subscription-based model, providing durable and predictable revenue streams, mitigating box office fluctuations and driving long-term customer loyalty. The stock is a compelling buy with a dividend yield of over 5% and accelerating revenue and EPS growth. The stock looks very attractive considering its depressed valuation, industry strength forecasted through 2019 coupled with a slew of company initiatives to drive the consumer experience.

Check out my previous article on AMC here.

Noah Kiedrowski
INO.com Contributor

Disclosure: The author does not hold shares in any of the mentioned stocks or ETFs. However, he may engage in options trading in any of the underlying securities. The author has no business relationship with any companies mentioned in this article. He is not a professional financial advisor or tax professional. This article reflects his own opinions. This article is not intended to be a recommendation to buy or sell any stock or ETF mentioned. Kiedrowski is an individual investor who analyzes investment strategies and disseminates analyses. Kiedrowski encourages all investors to conduct their own research and due diligence prior to investing. Please feel free to comment and provide feedback, the author values all responses. The author is the founder of www.stockoptionsdad.com where options are a bet on where stocks won’t go, not where they will. Where high probability options trading for consistent income and risk mitigation thrives in both bull and bear markets. For more engaging, short duration options based content, visit stockoptionsdad’s YouTube channel.